{"name":"Shenzhen Pregene Biopharma Co., Ltd.","slug":"shenzhen-pregene-biopharma-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNODdrbjVQREpWN1Q4Vk5qNDQ4ekROMjdCck5BWWlwY0Q1Y0Z5cWlEUE5xZWpiS2g5X3RuSDJMTUREdFF4dmVDWEp2THdtOWJHSkxxYjNOTm40bjY4MEFoQ1JLZ2xWbk5iOHppNTZ1LUdfems1OEdGeEd2V0pweVFoUDlpcERDbFYtQ2VfSnF0RVd2WlFSZkgyWFJHWmZzcG8?oc=5","date":"2026-02-18","type":"deal","source":"BioWorld News","summary":"Gilead-Genhouse's $1.5B+ deal boosts synthetic lethality push - BioWorld News","headline":"Gilead-Genhouse's $1.5B+ deal boosts synthetic lethality push","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPcUdNWDA2bVhCdzY3THRzV2Q3NjNNMkNWbXpsbk42RThsLU9RWTFqb3dnbzA2SFBpTGJEN2plLXN0MDBpQWFSQTNLUzRyWUhSOGlDTWhqOF9DV2ZzN1FVSmUxRmExSVBkd3RsLUxzczFIeUkwcFJoeDhGa19hcmxKb2R5TWR5ZTE3bWt5WV9RSDhUalRaQ0s4N3V0SDJlaFdJanc?oc=5","date":"2025-10-17","type":"pipeline","source":"BioSpace","summary":"Kite Makes $1.5B+ Cell Therapy Pact With Pregene as Others Pull Back - BioSpace","headline":"Kite Makes $1.5B+ Cell Therapy Pact With Pregene as Others Pull Back","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNRWRaTFZPaXdQOUg4VTlGcnEyZTliem05a1YwNW9fZVZaQXliMG9VVlVRaW1CLU96OTVjeEVXZGVPZkhMc0lIOUNuLVU3bHJFUWdDbm1BTzVVWm9vMll1VVVVOGU1dWFRTmRjb01HeEowVF9uRk1rTGxwdm5xbFRXODFUV0VxUmVxUEhVS09JV3BXb0RYRk5ZQ3A1b0JyQ3BmOHc?oc=5","date":"2025-10-16","type":"deal","source":"Fierce Biotech","summary":"Kite puts $1.6B on the line to pair up with China's Pregene for another in vivo CAR-T deal - Fierce Biotech","headline":"Kite puts $1.6B on the line to pair up with China's Pregene for another in vivo CAR-T deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxOTFRWdk1faWotclNmbkphcC1XeHJ0R0s0UnkyYnF6LVBrQjEycDZJSERQZnk4ZktwUTBHbG1wVTFSU1FxOHVTWUx3WTFnd2I3VlpnWDVEbUVEU05NN29zWlA3ZkFkMWU3YmotRno2S29NdUhWRTJadnc3SzFacVhnTjRwODJENnZXYVh4QzYxSjIwMG4zMnNjaG94VXdRellLZW5PbkpwTnY5RGl3VTlpUW5jYmtDb09iTTg5RHQ0ZG9tTDl0Zk1GQV9nS1R5WUxsOXpkeWtRcURYVEJvQ0dmNnZZSXlYUnBobk1PYw?oc=5","date":"2025-10-06","type":"pipeline","source":"PR Newswire","summary":"Lupus Nephritis Market to Advance at a CAGR of 8.5% During the Forecast Period (2025-2034) | DelveInsight - PR Newswire","headline":"Lupus Nephritis Market to Advance at a CAGR of 8.5% During the Forecast Period (2025-2034) | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTFA3Y3lrS1A1Xy1mVXVGWVNhdTgyM3lQWFIyZFBYOEtzby1Da2I0Y2RMYU43VGlNc0xETFV4a0txWjNkWm92RmVrdWthNTVmZXVpeHFiRVFuckpuRWlRLXVveFVVNmtxNUlSZ2txV2ExbGpnM1FnZWc?oc=5","date":"2025-01-08","type":"trial","source":"Oncology Pipeline","summary":"In vivo Car-T gains traction | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"In vivo Car-T gains traction | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAJBVV95cUxNcF84NE13YXNXLVJrb3NScTZRR0ttRldKZXQ5SmJQd0tBZldEM0lNYWtnZW9FN1N5ZjhJVno3LUdad2tmUS1ZZ2tLZmZ2QnJ5dmsyQ1owVEc3cG0yd0hIS0dHaTYxZmN4aVNVX2YzOUhEQXBJUVp0eDQteUlXVkZac3g2eS1HdThac2l3WW90LVJfbkI4Rk12dUpOUE5fbnlUTDk4VzJTSlk0bk9kZmZHTGFsbEsxdkszWC1PdGlpamtfTGNMZ0hNdE5aUTBjaFpNamZPV0Y0X0VlMXJWc0hBTjRKZ1BRbU5IcmtURkRjb0RwTmxqXzRUdzZ4Q1dmaVQ4aXc5TFJBTU9Nc1Y0UXA1OTNiVzJ3U1lBZDEyRGNrS2JGM0tQbmVodnJVNmM?oc=5","date":"2024-12-03","type":"trial","source":"PR Newswire","summary":"Lupus Nephritis Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 30+ Companies Working in the Domain - PR Newswire","headline":"Lupus Nephritis Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 30+ C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxQYXlpWWtJNGNLZHJEeWRMRnR6R0E2SVY5eElibzV2ZDlyaGZ0cDNLd3Z4V2hIVWpoZlA1LUw5SEd6SHRHbWNva1VQcUExU1FQN1lWV3pBN2M4aUktay16cGpCc2pPc2xsOWlwUzBvMXFGbmduaG5OdE1mZEM5aEdlN3BsNU1LNER4eWtScEpHb1hKUllUWm1OSndEM3MySmF6d3VPY0Q5ZVFjclBWUG5TMGNpODhhYWdiUlFQbV94T0g1T3RyZ2FnOWlhS0Z1c0xpNnExUGJBMTJfSGNGR01paGlveU5mazNqMV9JM1FIX1FlSzUwSjJ4VEtBWjVtWTVfTmpteW9n?oc=5","date":"2024-11-19","type":"regulatory","source":"PR Newswire","summary":"Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsight - PR Newswire","headline":"Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsigh","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxOOXluekdpTUZadk43bktrb1RLNGM0LWJNMVJBZm0yQ0Z1bnE5ZGk3eUFxTjNsVUlHTGE2OW9OTWRaWEU1STBNY05CVWVaT2JDcnlZcWx2dXlPRmJpaUdySTVndV9ZV2NoYnZuZVlxY1dqRjdjc2VxcW1VX3VTRXlYcldNd1JnSWNrM3NXb05mTDdvVXBZZ2FWTmpoN2R5NTZBajJMLWdrQXc5b0tWS3RHUE9qUFpTdzBHaEpxaUlzOUNjMXFubkhDdDRSa18wcEs1MHhiRWJDallycVRSRU8xTzRsU3N4ZXgtY183cUd5NXhyUWdHVmlNbnlJcUtaVjFGWktXQkZxMWFEQlRXMXc0OXRhTlh5bXg5eDliUUdDbUp1YTB6azJRWU5B?oc=5","date":"2021-07-29","type":"deal","source":"PPF Group","summary":"Athenex agreed to acquired Kuur for $185 million adding CAR-NKT platform - PPF Group","headline":"Athenex agreed to acquired Kuur for $185 million adding CAR-NKT platform","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2021-05-16","type":"pipeline","source":"medicaldialogues.in","summary":"Dr Reddys, Pregene collaborate for anti-BCMA CAR-T PRG1801 in India - medicaldialogues.in","headline":"Dr Reddys, Pregene collaborate for anti-BCMA CAR-T PRG1801 in India","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}